Evidence map›Paper›PMID 39373571›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2024

Early rapid local impedance drop is associated with acute lesion efficacy during pulmonary vein isolation.

Péter Perge, Nikola Petrovic, Zoltán Salló, Katalin Piros, Vivien Klaudia Nagy, Pál Ábrahám, István Osztheimer, Béla Merkely, László Gellér, Nándor Szegedi

Abstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Péter PergeHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0003-1256-3532
Nikola PetrovicBoston Scientific International B.V., Kerkrade, The Netherlands.ORCID 0009-0005-5185-9864
Zoltán SallóHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0002-2320-3535
Katalin PirosHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0002-1428-3588
Vivien Klaudia NagyHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0001-6878-1892
Pál ÁbrahámHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0001-5645-9855
István OsztheimerHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0002-8209-990X
Béla MerkelyHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0001-6514-0723
László GellérHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0001-6802-6360
Nándor SzegediHeart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary.ORCID 0000-0001-5670-745X

Funding

European UnionHungarian Ministry of Culture and Innovation FEIF/6464/2021-ITM_SZERZMD-PhD Excellence Program of Semmelweis University EFOP-3.6.3VEKOP-16-2017-00009National Academy of Scientist Education ProgramNational Biomedical FoundationNational Research, Development and Innovation FundNational Research, Development and Innovation Office of Hungary NVKP_161-2016-0017New National Excellence Program of the Ministry for Culture and Innovation
6 · The paper itself

Abstract

aimsThe predictive role of local impedance (LI) drop in lesion formation using a novel contact force sensing ablation catheter was recently described. The purpose of our current study was to assess the temporal characteristics of LI drop during ablation and its correlation with acute lesion efficacy. METHODS AND

resultsPoint-by-point pulmonary vein isolation was performed. The efficacy of applications was determined by pacing along the circular ablation line and assessing loss of capture. Local impedance, contact force, and catheter position data with high resolution were analysed and compared in successful and unsuccessful applications. Five hundred and fifty-nine successful and 84 unsuccessful applications were analysed. The successful applications showed higher baseline LI (P < 0.001) and larger LI drop during ablation (P < 0.001, for all). In case of unsuccessful applications, after a moderate but significant drop from baseline to the 2 s time point (153 vs. 145 Ω, P < 0.001), LI did not change further (P = 0.99). Contradictorily, in case of successful applications, the LI significantly decreased further (baseline-2 s-10 s: 161-150-141 Ω, P < 0.001 for all). The optimal cut-point for the LI drop indicating unsuccessful application was <9 Ω at the 4-s time point [AUC = 0.73 (0.67-0.76), P < 0.001]. Failing to reach this cut-point predicted unsuccessful applications [OR 3.82 (2.34-6.25); P < 0.001].

conclusionA rapid and enduring drop of the LI may predict effective lesion formation, while slightly changing or unchanged LI is associated with unsuccessful applications. A moderate LI drop during the first 4 s of radiofrequency application predicts ineffective radiofrequency delivery.

Indexed as

Atrial FibrillationCatheter AblationElectric ImpedancePulmonary VeinsAgedCardiac CathetersFemaleHumansMaleMiddle AgedTime FactorsTreatment OutcomeAtrial fibrillationCatheter ablationLocal impedancePulmonary vein isolation

Identifiers

PMID39373571
PMCPMC11493088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.